Research ArticleImmunotherapy

Anti–CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response

See allHide authors and affiliations

Science Translational Medicine  17 Sep 2014:
Vol. 6, Issue 254, pp. 254ra128
DOI: 10.1126/scitranslmed.3008918

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine